KLK3 and prostate carcinoma: Historically, prostate cancer detection relied heavily on prostate-specific antigen (PSA) screening and systematic transrectal ultrasound (TRUS)-guided biopsies, which often led to the overdiagnosis of indolent cancers while missing clinically significant ones [33].